Literature DB >> 15831922

Epidemiology of gastro-oesophageal reflux disease: a systematic review.

J Dent1, H B El-Serag, M-A Wallander, S Johansson.   

Abstract

A systematic review of the epidemiology of gastro-oesophageal reflux disease (GORD) has been performed, applying strict criteria for quality of studies and the disease definition used. The prevalence and incidence of GORD was estimated from 15 studies which defined GORD as at least weekly heartburn and/or acid regurgitation and met criteria concerning sample size, response rate, and recall period. Data on factors associated with GORD were also evaluated. An approximate prevalence of 10-20% was identified for GORD, defined by at least weekly heartburn and/or acid regurgitation in the Western world while in Asia this was lower, at less than 5%. The incidence in the Western world was approximately 5 per 1000 person years. A number of potential risk factors (for example, an immediate family history and obesity) and comorbidities (for example, respiratory diseases and chest pain) associated with GORD were identified. Data reported in this systematic review can be interpreted with confidence as reflecting the epidemiology of "true" GORD. The disease is more common in the Western world than in Asia, and the low rate of incidence relative to prevalence reflects its chronicity. The small number of studies eligible for inclusion in this review highlights the need for global consensus on a symptom based definition of GORD.

Entities:  

Mesh:

Year:  2005        PMID: 15831922      PMCID: PMC1774487          DOI: 10.1136/gut.2004.051821

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  53 in total

1.  Genetic influences in gastro-oesophageal reflux disease: a twin study.

Authors:  I Mohammed; L F Cherkas; S A Riley; T D Spector; N J Trudgill
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Racial differences in the prevalence of heartburn.

Authors:  S Rajendra; S Alahuddin
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171

3.  Prevalence of upper gastrointestinal symptoms in the general population: a systematic review.

Authors:  R C Heading
Journal:  Scand J Gastroenterol Suppl       Date:  1999

4.  Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population.

Authors:  M Diaz-Rubio; C Moreno-Elola-Olaso; E Rey; G R Locke; F Rodriguez-Artalejo
Journal:  Aliment Pharmacol Ther       Date:  2004-01-01       Impact factor: 8.171

5.  Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study.

Authors:  W M Wong; K C Lai; K F Lam; W M Hui; W H C Hu; C L K Lam; H H X Xia; J Q Huang; C K Chan; S K Lam; B C Y Wong
Journal:  Aliment Pharmacol Ther       Date:  2003-09-15       Impact factor: 8.171

6.  Gastro-esophageal reflux disease in northwestern Tabriz, Iran.

Authors:  Manochehr Khoshbaten
Journal:  Indian J Gastroenterol       Date:  2003 Jul-Aug

7.  Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men.

Authors:  Y Watanabe; Y Fujiwara; M Shiba; T Watanabe; K Tominaga; N Oshitani; T Matsumoto; H Nishikawa; K Higuchi; T Arakawa
Journal:  Scand J Gastroenterol       Date:  2003-08       Impact factor: 2.423

8.  Epidemiology of reflux disease and CLE in East Asia.

Authors:  Michio Hongo; Tomotaka Shoji
Journal:  J Gastroenterol       Date:  2003-03       Impact factor: 7.527

9.  Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization.

Authors:  Wai Man Wong; Kwok Fai Lam; Cecilia Cheng; Wai Mo Hui; Harry Hua-Xiang Xia; Kam Chuen Lai; Wayne H C Hu; Jia Qing Huang; Cindy L K Lam; Chi Kuen Chan; Annie O O Chan; Shiu Kum Lam; Benjamin Chun-Yu Wong
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

10.  Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease.

Authors:  David A Johnson; M Brian Fennerty
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  497 in total

Review 1.  How to Assess, Control, and Manage Uncontrolled CRS/Nasal Polyp Patients.

Authors:  Rahuram Sivasubramaniam; Richard J Harvey
Journal:  Curr Allergy Asthma Rep       Date:  2017-09       Impact factor: 4.806

2.  Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.

Authors:  Marc A Ward; Christy M Dunst; Ezra N Teitelbaum; Valerie J Halpin; Kevin M Reavis; Lee L Swanström; Steven R DeMeester
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

3.  Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.

Authors:  Tiberiu Hershcovici; Ronnie Fass
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

Review 4.  Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.

Authors:  Arne Kandulski; Peter Malfertheiner
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-22       Impact factor: 46.802

Review 5.  Canadian Digestive Health Foundation Public Impact Series: gastroesophageal reflux disease in Canada: incidence, prevalence, and direct and indirect economic impact.

Authors:  Richard N Fedorak; Sander Veldhuyzen van Zanten; Ron Bridges
Journal:  Can J Gastroenterol       Date:  2010-07       Impact factor: 3.522

6.  Internal herniation of the anterior gastric wall through an attenuated Nissen Fundoplication wrap: an unusual complication and its laparoscopic management.

Authors:  D Chattopadhyay; K S Wynne
Journal:  Hernia       Date:  2010-08-08       Impact factor: 4.739

7.  Acid control cannot be improved with a modified-release formulation of a proton pump inhibitor compared with twice-daily dosing of the conventional formulation.

Authors:  Kerstin Röhss; Clive Wilder-Smith; Sara Bokelund-Singh; Mohamed Sagar; Péter Nagy
Journal:  Dig Dis Sci       Date:  2010-03-18       Impact factor: 3.199

8.  Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area.

Authors:  Sushil Kumar; Saurabh Sharma; Tsering Norboo; Diskit Dolma; Angchuk Norboo; Tsering Stobdan; S Rohatgi; K Munot; Vineet Ahuja; Anoop Saraya
Journal:  Indian J Gastroenterol       Date:  2010-12-23

9.  Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats.

Authors:  Zullyt Zamora; Vivian Molina; Rosa Mas; Yazmin Ravelo; Yohany Perez; Ambar Oyarzabal
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

10.  Gastroesophageal reflux disease and antireflux surgery-what is the proper preoperative work-up?

Authors:  Brian Bello; Marco Zoccali; Roberto Gullo; Marco E Allaix; Fernando A Herbella; Arunas Gasparaitis; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2012-10-23       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.